I just pointed out that it wasn't new. Kelly posted a link (on FB group page) to the online article back in December, and it was discussed here with some excitement at that time. Along with the other case studies. Like this one:
>>>I will go with the findings and the opinion of Dr Brian Ilfeld, who has done dozens and dozens of clinical studies,<<<
And I will go with how this and all other stockholders have benefited with all these trials. How this management has capitalized on these trials and those 5 USA FDA CLEARANCES. Yes this leadership knows how to spend money, but has a big problem making it ($$$).